Literature DB >> 3901114

US of the upper abdomen: factors influencing image quality.

E E Windler, F L Lempp.   

Abstract

A controlled blind study of 226 patients was performed to determine the advantages of fasting prior to upper abdominal ultrasonography (US) as well as the influence of other factors on image quality. The ratio of weight to height (a reflection of body build) was found to most often correlate negatively with image quality for all organs, followed by age for the biliary tract, pancreas, and kidneys and sex (in males) for the pancreas. Only the biliary tract was shown slightly better as the result of fasting. Images obtained during the afternoon tended to be somewhat better. The authors conclude that upper abdominal US can be performed at any time in patients who have not fasted, as it is primarily other factors that determine image quality. Only if evaluation of the biliary tract is inconclusive need the patient be reexamined after fasting.

Entities:  

Mesh:

Year:  1985        PMID: 3901114     DOI: 10.1148/radiology.157.2.3901114

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  The potential role of modern US in the follow-up of patients with retroperitoneal fibrosis.

Authors:  Lars Kamper; Alexander Sascha Brandt; Hendrik Ekamp; Matthias Hofer; Stephan Roth; Patrick Haage; Werner Piroth
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

2.  Ultrasound evaluation of cholelithiasis in the morbidly obese.

Authors:  M S Silidker; J J Cronan; F H Scola; M M Moore; B Schepps; W Thompson; G S Dorfman
Journal:  Gastrointest Radiol       Date:  1988-10

3.  Usefulness of Ultrasonography for Diagnosis of Small Bowel Tumors: A Comparison Between Ultrasonography and Endoscopic Modalities.

Authors:  Minoru Fujita; Noriaki Manabe; Keisuke Honda; Takahisa Murao; Motoyasu Osawa; Ryosuke Kawai; Takashi Akiyama; Akiko Shiotani; Ken Haruma; Jiro Hata
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.